Bengt Baron
Enzymatica Chairman: “Our new research data makes 2024 an exciting year”
During 2023, Enzymatica has presented important research results for ColdZyme and strengthened the marketing of the product. However, sales have...
Enzymatica's new CEO takes office earlier than planned
Enzymatica announces that Claus Egstrand will take on the role of...
Enzymatica appoints Claus Egstrand as new CEO
The board of directors of the medical technology company Enzymatica announced this week that...
Enzymatica's Q1 report shows that the pandemic is affecting sales
A halved cold medicine market as a result of the pandemic has...
Enzymatica's Chairman of the Board on the new share issue
The board of Enzymatica has decided to implement a...
Enzymatica on reduced sales and planned new share issue
Covid-19-p
Enzymatica has paved the way for continued growth
Last week, Enzymatica published its fourth quarter results...
BioStock Studio: Enzymatica's Chairman on the successes in 2020
This morning Enzymatica published its fourth quarter report...
Enzymatica's COO comments on this year's successes
Enzymatica has lined up many positive messages during...
New record quarter for Enzymatica
Enzymatica today reported its second consecutive quarter...
Enzymatica reshuffles company management
As Enzymatica's current CEO Fredrik Lindberg will...
User survey shows that ColdZyme works for children
Today a new study came out from Enzymatica regarding...